Patient-oriented SCORAD: a self-assessment score in atopic dermatitis. A preliminary feasibility study
- PMID:19147989
- DOI: 10.1159/000193997
Patient-oriented SCORAD: a self-assessment score in atopic dermatitis. A preliminary feasibility study
Abstract
Background: The SCORing Atopic Dermatitis (SCORAD) index is used worldwide to assess the severity of atopic eczema. Patient involvement in the treatment process is of major current interest. There are very few validated patient self-assessment tools for atopic dermatitis (AD).
Objective: To develop a self-assessment score for AD patients, the patient-oriented SCORAD (PO-SCORAD) based on the SCORAD index, and to assess its acceptability in a pilot study.
Methods: A multicenter working group decided on the initial form of the PO-SCORAD. A prospective, single-center pilot study was then carried out to assess its acceptability and validity. A SCORAD and a PO-SCORAD were applied at baseline and after 18 days; the acceptability of the tool was assessed by questionnaire, its validity by comparing SCORAD and PO-SCORAD on both visits.
Results: The study involved 15 children and 18 adults. 80% of the respondents found the questions clear and the form easy to fill in; 96% spent less than 10 min on it. A correlation was found between the SCORAD and the PO-SCORAD.
Conclusion: This study shows that self-assessment is feasible in AD, and that there is a correlation between the physician and the patient scores. This study was the first step in validating the PO-SCORAD.
2009 S. Karger AG, Basel
Similar articles
- Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe.Stalder JF, Barbarot S, Wollenberg A, Holm EA, De Raeve L, Seidenari S, Oranje A, Deleuran M, Cambazard F, Svensson A, Simon D, Benfeldt E, Reunala T, Mazereeuv J, Boralevi F, Kunz B, Misery L, Mortz CG, Darsow U, Gelmetti C, Diepgen T, Ring J, Moehrenschlager M, Gieler U, Taïeb A; PO-SCORAD Investigators Group.Stalder JF, et al.Allergy. 2011 Aug;66(8):1114-21. doi: 10.1111/j.1398-9995.2011.02577.x. Epub 2011 Mar 18.Allergy. 2011.PMID:21414011
- The objective severity assessment of atopic dermatitis (OSAAD) score: validity, reliability and sensitivity in adult patients with atopic dermatitis.Angelova-Fischer I, Bauer A, Hipler UC, Petrov I, Kazandjieva J, Bruckner T, Diepgen T, Tsankov N, Williams M, Fischer TW, Elsner P, Fluhr JW.Angelova-Fischer I, et al.Br J Dermatol. 2005 Oct;153(4):767-73. doi: 10.1111/j.1365-2133.2005.06697.x.Br J Dermatol. 2005.PMID:16181458
- Analysis of correlations between patient-oriented SCORAD (PO-SCORAD) and other assessment scores of atopic dermatitis severity and quality of life.Coutanceau C, Stalder JF.Coutanceau C, et al.Dermatology. 2014;229(3):248-55. doi: 10.1159/000365075. Epub 2014 Aug 29.Dermatology. 2014.PMID:25196258
- Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score.Oranje AP, Glazenburg EJ, Wolkerstorfer A, de Waard-van der Spek FB.Oranje AP, et al.Br J Dermatol. 2007 Oct;157(4):645-8. doi: 10.1111/j.1365-2133.2007.08112.x. Epub 2007 Aug 21.Br J Dermatol. 2007.PMID:17714568Review.
- Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation.Schmitt J, Langan S, Deckert S, Svensson A, von Kobyletzki L, Thomas K, Spuls P; Harmonising Outcome Measures for Atopic Dermatitis (HOME) Initiative.Schmitt J, et al.J Allergy Clin Immunol. 2013 Dec;132(6):1337-47. doi: 10.1016/j.jaci.2013.07.008. Epub 2013 Sep 12.J Allergy Clin Immunol. 2013.PMID:24035157Review.
Cited by
- IL-4 Gene Polymorphism May Contribute to an Increased Risk of Atopic Dermatitis in Children.Shang H, Cao XL, Wan YJ, Meng J, Guo LH.Shang H, et al.Dis Markers. 2016;2016:1021942. doi: 10.1155/2016/1021942. Epub 2016 Apr 24.Dis Markers. 2016.PMID:27212784Free PMC article.
- Tolerability and Efficacy of a Medical Device Repairing Emollient Cream in Children and Adults with Mild to Moderate Atopic Dermatitis.Pinter A, Thouvenin MD, Bacquey A, Rossi AB, Nocera T.Pinter A, et al.Dermatol Ther (Heidelb). 2019 Jun;9(2):309-319. doi: 10.1007/s13555-019-0295-0. Epub 2019 Apr 9.Dermatol Ther (Heidelb). 2019.PMID:30968310Free PMC article.
- How the Smartphone Is Changing Allergy Diagnostics.Pereira AM, Jácome C, Almeida R, Fonseca JA.Pereira AM, et al.Curr Allergy Asthma Rep. 2018 Oct 25;18(12):69. doi: 10.1007/s11882-018-0824-4.Curr Allergy Asthma Rep. 2018.PMID:30361774Review.
- Efficacy and Tolerability of a Medical Device Repairing Emollient Cream Associated with a Topical Corticosteroid in Adults with Atopic Dermatitis: An Open-label, Intra-individual Randomized Controlled Study.Rossi AB, Bacquey A, Nocera T, Thouvenin MD.Rossi AB, et al.Dermatol Ther (Heidelb). 2018 Jun;8(2):217-228. doi: 10.1007/s13555-018-0228-3. Epub 2018 Mar 6.Dermatol Ther (Heidelb). 2018.PMID:29511936Free PMC article.
- Strategies for using topical corticosteroids in children and adults with eczema.Lax SJ, Harvey J, Axon E, Howells L, Santer M, Ridd MJ, Lawton S, Langan S, Roberts A, Ahmed A, Muller I, Ming LC, Panda S, Chernyshov P, Carter B, Williams HC, Thomas KS, Chalmers JR.Lax SJ, et al.Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013356. doi: 10.1002/14651858.CD013356.pub2.Cochrane Database Syst Rev. 2022.PMID:35275399Free PMC article.Review.
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources